The Oxford-AstraZeneca COVID vaccine is showing signs of promoting immune response within older adults, according to a new study.

What’s going on?

CNBC reports that new research has found that the coronavirus vaccine from Oxford and AstraZeneca is safe and creates a strong immune response among all adults.

  • The study — published in The Lancet — found the vaccine to be safe and produced an immune response among people who are 56 years old and older, as well as those who are 18 to 55 years old.
  • The researchers studied 560 healthy adults for the study.

Why this matters:

The study should be considered “encouraging” since older adults remain at high risk for severe conditions over the virus, Fox News reports.

  • The researchers said the “findings are encouraging” because of how it would help at-risk individuals.

Key quote:

  • “We’re really delighted with the results,” professor Andrew Pollard, the leader of Oxford’s vaccine trial team, told CNBC. “In this study, we have … been trying to examine the immune responses in older adults and address this question that has been out there about as you get older whether the immune system is less able to respond,” Pollard said.